Articles On Telix Pharmaceuticals (ASX:TLX)

Title Source Codes Date
ASX Health Stocks: Mesoblast raise signals potential comeback for biotechs

Recent cap raising suggests biotechs may finally be making a comeback Mesblast annnounced a US$45m cap raise last week Today, Paradigm, Opthea, and Proteomics also announced fund raises Over the past year, the biotech sector has been caug...

Stockhead TLX 17 hours ago
Lunch Report: 12 August, 2022

ShareCafeLunch Report: 12 August, 2022 by Paul Sanger   At noon, the S&P/ASX 200 is 0.42 per cent or 29.50 points lower at 7041.50. The SPI futures are pointing to a fall of 32 points. Best and worst performers The best-performing secto...

ShareCafe TLX 3 days ago
China’s Grand Decade drops $73m Telix stake, JPM seeks buyers

JPMorgan’s equities desk is seeking buyers about a 3 per cent stake in ASX-listed Telix Pharmaceuticals on Thursday evening. 

AFR TLX 4 days ago
Telix and UQ-led consortium awarded Australian Research Council grant

Telix (ASX:TLX) has announced that it has been jointly awarded a $4.8 million Australian Research Council grant to establish a new Industrial Transformation Research Program Hub as part of a consortium of applicants led by The Unive...

BiotechDispatch TLX 6 days ago
Telix and University of Queensland-led Consortium Awarded $5M Australian Research Council (ARC) Grant

MELBOURNE, Australia, Aug. 8, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has been jointly awarded a $4.8 million Australian Research Council (ARC) grant to establish a new Ind...

FNArena TLX 1 week ago
Up 50% in a month: Why all these fundies predict more greatness for the Telix Pharmaceuticals share price

The Telix Pharmaceuticals Ltd (ASX: TLX) share price finished the session on Friday up 0.52% to $7.79. Over the past month, the ASX healthcare share has risen in value by an extraordinary 50.1%. Contributing to this gain was the investor...

Motley Fool TLX 1 week ago
ScoPo’s Powerplays: ‘Big haircuts’ for ASX health stocks Morgans reviews quarterly results

Healthcare and life sciences expert Scott Power, who has been a senior analyst with Morgans Financial for 24 years, explains what the movers and shakers have been doing in health and gives his ASX Powerplays. Morgans takes conservative app...

Stockhead TLX 1 week ago
Global Biotech Turnaround Looks to Be Underway

ShareCafeGlobal Biotech Turnaround Looks to Be Underway Signs of life are emerging in the global biotech sector, after the longest and sharpest downturn in history that was so severe it left hundreds US companies trading below cash backing....

ShareCafe TLX 1 week ago
Here are the top 10 ASX 200 shares today

The S&P/ASX 200 Index (ASX: XJO) slipped ever so slightly on Thursday after major commodity prices tumbled overnight. The index was 0.01% lower at 6,974.90 points as of the market’s close. The slip came despite a decent performance b...

Motley Fool TLX 1 week ago
ASX Close: Market finishes flat as early rally fades

The ASX 200 finished little changed after failing to sustain a push above 7000. The Australian benchmark hit a seven-week high of 7021 in the first half hour before a session-long fade stripped its gains. The index finished a single poin...

themarketherald.com.au TLX 1 week ago
ASX Update: Stocks trim gains, lose hold on 7000

The S&P/ASX 200 traded briefly above 7000 after oil fell to a six-month low and upbeat US economic data soothed global recession worries. The Australian benchmark touched a seven-week high of 7021 before shaving its advance to 12 poi...

themarketherald.com.au TLX 1 week ago
Here are the top 10 ASX 200 shares today

The S&P/ASX 200 Index (ASX: XJO) defied its earlier downturn to close higher after the Reserve Bank of Australia (RBA) lifted interest rates for a fourth consecutive month. The index was 0.07% higher at 6,998.10 points at Tuesday’s c...

Motley Fool TLX 1 week ago
Why A2 Milk, Qualitas, Telix, and Ventia shares are pushing higher today

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has fought back and is edging slightly higher. At the time of writing, the benchmark index is up to 6,994.9 points. Four ASX shares that are climbing more than most today are listed...

Motley Fool TLX 1 week ago
Lunch Report: 2 August, 2022

ShareCafeLunch Report: 2 August, 2022 by Paul Sanger   The Reserve Bank of Australia is expected to hike by 50 basis points after official data showed prices in Australia rose 6.1 per cent in the second quarter compared with a year ago. At...

ShareCafe TLX 1 week ago
Telix APAC Report: Regulatory Progress for Prostate and Kidney Cancer Imaging

MELBOURNE, Australia, Aug. 2, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today reports on regulatory progress for the Company’s core prostate and kidney cancer imaging programs in the Asia Pacific (A...

FNArena TLX 1 week ago
Monkeypox cases rising in Australia; Will healthcare giants be impacted?

Highlights:  WHO has declared Monkeypox a global health emergency as cases have surfaced in 74 countries sofar. In Australia, so far, 44 confirmed cases of Monkeypox have been confirmed. Monkeypox is a disease that causes rash turning...

Kalkine Media TLX 2 weeks ago
Monkeypox cases rising in Australia; Will healthcare giants be impacted?

Highlights:  WHO has declared Monkeypox a global health emergency as cases have surfaced in 74 countries sofar. In Australia, so far, 44 confirmed cases of Monkeypox have been confirmed. Monkeypox is a disease that causes rash turning...

Kalkine Media TLX 2 weeks ago
Health Is Wealth

In times of great uncertainty the Australian healthcare sector can offer investors plenty of choice, with varying degrees of risk and opportunities. -Australia’s healthcare sector has seen record government investment-Global pandemic has ac...

FNArena TLX 2 weeks ago
Here are the top 10 ASX 200 shares today

After a wobbly start to the day, the S&P/ASX 200 Index (ASX: XJO) posted a gain for the first time in three sessions after lacklustre performances yesterday and on Friday. At the end of Tuesday’s trade, the index was up 0.26% at 6,...

Motley Fool TLX 2 weeks ago
ASX Close: Best week since March as buyers return

The share market logged its best week since March as a six-week high on Wall Street bolstered confidence this year’s market rout may be easing.   The S&P/ASX 200 eased three points or 0.04 per cent today, falling narrowly short of a...

themarketherald.com.au TLX 3 weeks ago
Why Brickworks, Ioneer, Telix, and Zip shares are charging higher

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small gain. At the time of writing, the benchmark index is up 0.1% to 6,800.9 points. Four ASX shares that are climbing more than most today are listed bel...

Motley Fool TLX 3 weeks ago
Lunch Report: 22 July, 2022

ShareCafeLunch Report: 22 July, 2022 by Paul Sanger   The S&P/ASX 200 traded flat by midday in Sydney after spending much of the morning in negative territory. The benchmark erased early losses after opening 0.5 per cent lower and brief...

ShareCafe TLX 3 weeks ago
ASX Update: Shares overcome early weakness; BNPL leads again

Australian shares gained momentum late morning, rising for a third session despite weak earnings from social media giant Snap weighing on US futures. The S&P/ASX 200 overcame early weakness to reach the halfway mark 16 points or 0.24...

themarketherald.com.au TLX 3 weeks ago
Evening Report: 21 July, 2022

ShareCafeEvening Report: 21 July, 2022 by Paul Sanger   At the closing bell, the S&P/ASX 200 was 0.52 per cent or 35.10 points higher at 6794.30. The lithium and green metals sector was on fire today, after electric vehicle maker Tesla...

ShareCafe TLX 3 weeks ago
ASX Large Caps: Late rally puts smile back on blue chips as tech and lithium stocks shine

ASX closes 0.30% higher after being in the red Lithium stocks rise on Tesla guidance Woodside down despite bumper revenue After trading in red for most of the day, the ASX 200 finished Thursday 0.40 higher at 6,784. Energy stocks dragged...

Stockhead TLX 3 weeks ago
ASX Close: Late rally powers ASX 200 to five-week high

A late rally lifted the Australian share market to its strongest close in five weeks as strength in bank and tech stocks outweighed pressure on iron ore miners after China established a steelmakers’ purchasing cartel. The S&P/ASX 200...

themarketherald.com.au TLX 3 weeks ago
Strong launch for Telix imaging agent

Melbourne-based Telix Pharmaceuticals says it made $19.3m in just 10 weeks after beginning US sales of its new prostate cancer diagnostic imaging agent.

The West TLX 3 weeks ago
Telix Pharmaceuticals (ASX:TLX) posts ten-fold revenue increase in Q4

Telix Pharmaceuticals (TLX) reports more than a ten-fold quarter-on-quarter revenue increase for the three months ending June 30 The healthcare company received $22.5 million in total revenue which reflects sales of its prostate cancer ima...

themarketherald.com.au TLX 3 weeks ago
ASX Update: Shares mark time as ore miners, oilers weigh

The share market hovered near a three-week high as declines in resource stocks outweighed gains in growth sectors. The S&P/ASX 200 eased five points or 0.07 per cent by lunchtime. The Australian benchmark struggled for direction afte...

themarketherald.com.au TLX 3 weeks ago
Lunch Report: 21 July, 2022

ShareCafeLunch Report: 21 July, 2022 by Paul Sanger   Australian shares are little changed in mixed trading this morning. At noon, the S&P/ASX 200 is 0.05 per cent or 3.60 points lower at 6755.60. Australian lithium and nickel companies...

ShareCafe TLX 3 weeks ago
Stocks of the Hour: 21 July, 2022

ShareCafeStocks of the Hour: 21 July, 2022                  Orthocell (ASX:OCC) recently signed a global exclusive licence and distribution agreement with BioHorizons Implant Systems Inc, one of the largest dental implant companies in...

ShareCafe TLX 3 weeks ago
ASX 200 midday update: ANZ’s capital raising, Link jumps, Zip’s Q4 update

At lunch on Thursday, the S&P/ASX 200 Index (ASX: XJO) is on course to record a small decline. The benchmark index is currently down 0.1% to 6,754.1 points. Here’s what is happening on the ASX 200 today: ANZ shares edge lower The Au...

Motley Fool TLX 3 weeks ago
Stocks of the Hour: Orthocell, Telix Pharmaceuticals, Asra Minerals

21 Jul 2022 - A snapshot of the stocks on the move featuring Orthocell (ASX:OCC), Telix Pharmaceuticals (ASX:TLX) and Asra Minerals (ASX:ASR).

FNN TLX 3 weeks ago
Telix share price soars 11% following ‘first commercial quarter’

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is pushing higher in trade today. At the time of writing, the share is trading more than 11% in the green at $6.21 apiece. Investors are bidding up the Telix share price following t...

Motley Fool TLX 3 weeks ago
ASX 200 opens flat; IT and Financial sectors mark marginal gains

Highlights: ASX 200 stocks opened a little lower today, however, the benchmark index recovered a bit and started trading flat after a while. The market has been taking cues from the Wall Street that ended lower in its last session thou...

Kalkine Media TLX 3 weeks ago
Telix Reports Second Quarter 2022 Financial Results

MELBOURNE, Australia, July 21, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow statement and accompanying Activities Report for the quarter ended 30 June 2...

FNArena TLX 3 weeks ago
ScoPo’s Powerplays: ASX health stocks up for second week, investors get reason to smile

Mach 7 announces patent infringement lawsuit settled in its favour Lumos Diagnostics tanks after device submission for FebriDX rejected by US FDA Three companies announce major milestones in clinical trials Healthcare and life sciences e...

Stockhead TLX 1 month ago
“Your Stock Request” – 14 July 2022

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

Fairmont Equities TLX 1 month ago
How did ASX biotech shares perform in FY22?

ASX biotech shares were hammered in FY22 with the sector facing heavy losses, in line with the wider technology sector. The ETFs S&P Biotech ETF (ASX: CURE), an index fund tracking the global biotech sector, is down almost 24% this y...

Motley Fool TLX 1 month ago
Telix Pharmaceuticals announces major leadership appointment

Telix Pharmaceuticals (ASX:TLX) has announced the appointment of a CEO for its Americas business and dosed the final patient and completed recruitment into the pivotal Phase 3 study, ZIRCON.

BiotechDispatch TLX 1 month ago
Telix Pharmaceuticals (ASX:TLX) recruits Kevin Richardson as CEO Telix Americas

Telix Pharmaceuticals (TLX) appoints Kevin Richardson to the role of CEO Telix Americas The senior global executive will step into the position from today, bringing with him 25 years of experience in the healthcare industry Dr Christian Be...

themarketherald.com.au TLX 1 month ago
ASX Health Stocks: Lumos down 65pc on FDA rejection; and is Hexima belly-up after Phase 2 readout?

Lumos’ FebriDX was rejected by the FDA Hexima hurt by unexpected readout from Phase 2 trial Anteris reports good progress on DurAVR study Some unexpected news have driven a couple ASX healthcare stocks down by double digits this morning....

Stockhead TLX 1 month ago
Lunch Report: 11 July, 2022

ShareCafeLunch Report: 11 July, 2022 by Melissa Darmawan   The fall in materials and information tech led the retreat on the Australian sharemarket as gains in energy and financial stocks weren’t enough to offset the decline. At noon, the S...

ShareCafe TLX 1 month ago
ZIRCON Phase III Kidney Cancer Imaging Study Completes Enrolment

MELBOURNE, Australia, July 11, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has dosed the final patient and completed recruitment into the Phase III pivotal study ZIRCON (Zircon...

FNArena TLX 1 month ago
Kevin Richardson appointed as CEO, Telix Americas

MELBOURNE and INDIANAPOLIS, July 11, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) is pleased to announce that Kevin Richardson, a senior global executive with a career focus on sales, marketing and bus...

FNArena TLX 1 month ago
Bell Potter names 2 of the best ASX healthcare shares to buy in FY23

This month I’ve been looking at a number of shares that Bell Potter has rated as its top picks for FY 2023. You can read about its tech picks here and its energy picks here. On this occasion, let’s take a look at a couple of ASX health...

Motley Fool TLX 1 month ago
Telix Pharmaceuticals (ASX:TLX) signs licence and distribution agreement for Illuccix

Telix Pharmaceuticals (TLX) signs a licence and distribution agreement with Isologic Innovative Pharmaceuticals for its investigational prostate cancer imaging agent Illuccix Under the agreement, Isologic will be the commercial distributor...

themarketherald.com.au TLX 1 month ago
ASX Update: 19-month low as pandemic gains shrivel

Aussie shares sank to their lowest level since November 2020 as recession fears continued to batter financial markets. The S&P/ASX 200 dived 136 points or 2.07 per cent towards a sixth straight loss. Barring a miraculous afternoon re...

themarketherald.com.au TLX 1 month ago
Telix and Invicro Advance AI Partnership

MELBOURNE, Australia and BOSTON, June 14, 2022 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has advanced a partnership with Invicro LLC (Invicro), a global, industry-leading imaging...

FNArena TLX 2 months ago
Telix and Invicro Advance AI Partnership

MELBOURNE, Australia and BOSTON, June 14, 2022 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has advanced a partnership with Invicro LLC (Invicro), a global, industry-leading imaging...

FNArena TLX 2 months ago